CRAM-PROMs: Changes in Reliability When Assessing Multiple Patient-Reported Outcome Measures

Sponsor
Hamilton Health Sciences Corporation (Other)
Overall Status
Recruiting
CT.gov ID
NCT04008680
Collaborator
(none)
110
1
4
19.5
5.6

Study Details

Study Description

Brief Summary

This study investigates how reliability of patient reported outcomes can be affected with questionnaire burden and and the number of questionnaires given to study participants.

Condition or Disease Intervention/Treatment Phase
  • Other: EQ-5D-5L survey internal consistency
N/A

Detailed Description

The primary objective of the study is to determine if the number of remotely administered questionnaires completed by fracture patients affects the psychometric properties of a questionnaire itself. We will assess the internal consistency of the EuroQuol Five Dimension

  • Five Level (EQ-5D-5L) Health Survey questionnaire as more questionnaires are applied.

The secondary objective is to evaluate how the number of questionnaires and the time it takes to complete them impact patient's preferences and values. We will measure the time taken by each participant to complete the EQ-5D-5L questionnaire to evaluate if it changes meaningfully as the number of questionnaires given to participants' increases. Additionally, we will assess patient preferences and values by asking how well the remotely collected PROMs reflect their health status, and how this changes relative to the number of questionnaires administered.

Our hypothesis is that there is a progressive decline in psychometric properties in the EQ-5D-5L, both in reliability and validity, as we increase the number of questionnaires given to participants. We also hypothesize that the time to complete the ED-5D-5L will increase as the number of questionnaires given to participants' increases, and that there is a threshold at which the patient feels there are no additional value to completing additional remote PROMS to adequately reflect their health status.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
110 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
4 group randomized clinical trial4 group randomized clinical trial
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Collection of Remotely Administered Multiple Patient-Reported Outcome Measures (CRAM-PROMs) in Orthopaedic Trauma: Assessment of the Impact of Quantity on Quality
Actual Study Start Date :
May 17, 2021
Anticipated Primary Completion Date :
Jul 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Low response burden

Participants will be assigned to complete only the EQ-5D-5L questionnaire.

Other: EQ-5D-5L survey internal consistency
To see how increasing the number of questionnaires affects the internal consistency of the EQ-5D-5L.

Other: Low to medium response burden

Participants will be assigned to complete the General Anxiety Disorder-7 (GAD-7) questionnaire first, followed by the EQ-5D-5L questionnaire.

Other: EQ-5D-5L survey internal consistency
To see how increasing the number of questionnaires affects the internal consistency of the EQ-5D-5L.

Other: Medium to high response burden

Participants will be assigned to complete the Pain Catastrophizing Scale (PCS) questionnaire first, followed by the GAD-7, and lastly the EQ-5D-5L questionnaire.

Other: EQ-5D-5L survey internal consistency
To see how increasing the number of questionnaires affects the internal consistency of the EQ-5D-5L.

Other: High response burden

Participants will be assigned to complete the Brief Pain Inventory (BPI) questionnaire first, followed by the PCS secondly, the GAD-7 third, and lastly the EQ-5D-5L questionnaire.

Other: EQ-5D-5L survey internal consistency
To see how increasing the number of questionnaires affects the internal consistency of the EQ-5D-5L.

Outcome Measures

Primary Outcome Measures

  1. Reliability and validity of the EQ-5D-5L [Day 1]

    The questionnaire selected to analyze reliability in our population is the EQ-5D-5L.This well-known, generic, patient-reported health questionnaire is frequently used in musculoskeletal research and has shown to have a good internal consistency. We will compute the Cronbach's alpha coefficient for the EQ-5D-5L questionnaire. We will contrast these results to analyze if there is any difference in the values obtained from the answers of the EQ-5D-5L questionnaire between the four groups.

Secondary Outcome Measures

  1. Time to completion [Day 1]

    Time to complete the questionnaire. We will collect data (through electronic software) on time to completion of the EQ-5D-5L questionnaire. We hypothesize that as patients are asked to complete more surveys, patients will fatigue as the research burden increases and take longer to complete the surveys. Data will be collected in minutes, and the mean time to completion will be compared across groups through analysis of variance tests.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. The patient presents to the in-person or virtual fracture clinic for his/her own appointment.

  2. The patient has a fracture that is being managed either operatively or non-operatively.

  3. Fracture occurred in the past 6 months.

  4. The patient is 18 years of age or older.

  5. The patient is able to read, understand, and write in English.

  6. Patient provides informed, verbal or written consent.

Exclusion Criteria:
  1. The patient is considered too ill or injured to participate in the study.

  2. The patient is cognitively impaired, intoxicated or otherwise unable to provide consent or participate in the study.

  3. The patient is co-enrolled in another study requiring completion of multiple additional PROMs.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hamilton Health Sciences - General Site Hamilton Ontario Canada

Sponsors and Collaborators

  • Hamilton Health Sciences Corporation

Investigators

  • Principal Investigator: Francesc Antoni Marcano-Fernandez, PhD, McMaster University
  • Principal Investigator: Herman Johal, MD, McMaster University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hamilton Health Sciences Corporation
ClinicalTrials.gov Identifier:
NCT04008680
Other Study ID Numbers:
  • HiREB 7607
First Posted:
Jul 5, 2019
Last Update Posted:
Jul 28, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hamilton Health Sciences Corporation

Study Results

No Results Posted as of Jul 28, 2021